Myelosuppression

Bone marrow suppression

Bone
Bone marrow suppression or myelotoxicity (adjective myelotoxic) or myelosuppression, which is decrease in cells responsible for providing immunity, carrying oxygen, and those responsible for normal blood clotting is a serious side effect of chemotherapy and certain drugs affecting the immune system such as azathioprine. The risk is especially high in cytotoxic chemotherapy for leukemia. Non-steroidal anti-inflammatory drugs, in some rare instances, may also cause bone marrow suppression. The decrease in blood cell counts does not occur right at the start of chemotherapy because the drugs do not destroy the cells already in the bloodstream (these are not dividing rapidly)...

Myelosuppression - List of case studies

Pulmonary heteroplasia

present an adequate somatostatin receptor density. Also, myelosuppression as well as renal problems should not be underestimated after ... differentiation), non small cell lung cancers, myelosuppression, renal problems.   Examinations : ...

Small Cell Neuroendocrine Tumor of the Cervix – additional opinion

entire group were 14.5 months, 33%, and 24%, respectively. Myelosuppression was the major toxicity (7). Another prospective trial ... neuroendocrine tumors, large cell neuroendocrine tumors, Myelosuppression, metastatic neuroendocrine carcinomas, NECs, ... neuroendocrine tumors, large cell neuroendocrine tumors, Myelosuppression, metastatic neuroendocrine carcinomas, NECs, ...

Endometrial Cancer

with the gain in survival. However, grade 3 and 4 myelosuppression and gastrointestinal toxicity are also increased. While no ... organ involvement, advanced endometrial cancer, myelosuppression, gastrointestinal toxicity, fluid retention, weight gain, ... organ involvement, advanced endometrial cancer, myelosuppression, gastrointestinal toxicity, fluid retention, weight gain, ...

JustAnswer.com